Related Experiment Video
Updated: Apr 17, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
18.9K
Chronic migraine - new treatment options
Adina Roceanu1, Florina Antochi1, Ovidiu Bajenaru1
1Department of Neurology, Emergency University Hospital, Bucharest, Romania.
Maedica
|February 24, 2015
Summary
New treatments offer hope for chronic migraine (CM) sufferers. Effective options include topiramate, onabotulinumtoxin A, and occipital nerve stimulation (ONS) for refractory cases.
Area of Science:
- Neurology
- Headache Medicine
Background:
- Chronic migraine (CM) involves frequent debilitating headaches.
- New therapeutic strategies are emerging for CM management.
Purpose of the Study:
- To review current and emerging treatment options for chronic migraine.
- To highlight the efficacy of specific interventions in CM.
Main Methods:
- Review of existing literature on CM treatments.
- Analysis of clinical trial data for topiramate, onabotulinumtoxin A, and occipital nerve stimulation (ONS).
Main Results:
- Topiramate demonstrates efficacy in CM, with or without medication overuse.
- Onabotulinumtoxin A is a proven preventive treatment for CM.
- Occipital nerve stimulation (ONS) shows promise for refractory CM patients.
Conclusions:
- Multiple effective treatment options are now available for chronic migraine.
- Interventional therapies like ONS offer new hope for difficult-to-treat CM cases.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
532
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
532
01:19Management of Insomnia
803
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
803
01:25Analgesia and Pain Management
3.2K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.2K
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:27Insomnia
611
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
611